Literature DB >> 19349140

[Intestinal perforation: an unusual adverse event of bevacizumab and paclitaxel combined therapy for a metastatic breast cancer].

Johanna Mychaluk1, Christine Piprot, Henri Sevestre, Philippe Merviel, Jean Gondry, Raffaèle Fauvet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19349140     DOI： 10.1016/j.lpm.2008.10.020

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0755-4982            Impact factor:   1.228


× No keyword cloud information.
  2 in total

1.  An Unusual Case of Colon Perforation With Multiple Transmural Ulcers After Use of Polmacoxib and Everolimus in a Metastatic Breast Cancer Patient.

Authors:  In-Gyu Song; Kyung Uk Jung; Hyung Ook Kim; Hungdai Kim; Ho-Kyung Chun
Journal:  Ann Coloproctol       Date:  2020-03-16

Review 2.  Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature.

Authors:  Yusuke Fujii; Noriyuki Hirahara; Syunsuke Kaji; Takahito Taniura; Ryoji Hyakudomi; Tetsu Yamamoto; Yoshitsugu Tajima
Journal:  J Med Case Rep       Date:  2018-03-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.